CN Patent

CN101171009A — 用非咪唑烷基胺组胺h3－受体的配体治疗帕金森症、阻塞性睡眠呼吸暂停、路易体痴呆、血管性痴呆

Assigned to Bioprojet SC · Expires 2008-04-30 · 18y expired

What this patent protects

本发明提供用构成组胺H 3 －受体拮抗剂的非咪唑烷基胺衍生物治疗帕金森症、阻塞性睡眠呼吸暂停、发作性睡眠症、路易体痴呆、血管性痴呆的新方法。

USPTO Abstract

本发明提供用构成组胺H 3 －受体拮抗剂的非咪唑烷基胺衍生物治疗帕金森症、阻塞性睡眠呼吸暂停、发作性睡眠症、路易体痴呆、血管性痴呆的新方法。

Drugs covered by this patent

pitolisant-hydrochloride (PITOLISANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN101171009A
Jurisdiction: CN
Classification: —
Expires: 2008-04-30
Drug substance claim: No
Drug product claim: No
Assignee: Bioprojet SC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.